Infliximab in the treatment of plaque type psoriasis
Rosita Saraceno, Andrea Saggini, Lucia Pietroleonardo, Sergio ChimentiDepartment of Dermatology, University of Rome Tor Vergata, Rome, Viale Oxford 81, Rome, ItalyAbstract: Psoriasis is a chronic and immunomediated skin disease characterized by erythematous scaly plaques. Psoriasis affects approxima...
Saved in:
Main Authors: | Rosita Saraceno (Author), Andrea Saggini (Author), Lucia Pietroleonardo (Author), Sergio Chimenti (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013) -
Treatment of severe psoriasis with infliximab
by: JA Leman, et al.
Published: (2008) -
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019) -
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
by: Giunta A, et al.
Published: (2017) -
Diffused suberitrodermic psoriasis induced by infliximab
by: V. Bruzzese
Published: (2011)